Integrative Homeopathic Treatment as Adjunctive Therapy in Breast Cancer: A Prospective Case Series on Quality of Life Improvements
DOI:
https://doi.org/10.64149/J.Carcinog.24.2s.803-810Abstract
Background: The integration of homoeopathic medicine as adjunctive therapy in breast cancer management remains an area of growing clinical interest, particularly for managing treatment-related side effects and improving quality of life (QoL).
Objective: To evaluate the effectiveness of individualised homoeopathic treatment as add-on therapy in breast cancer patients receiving conventional treatment, with specific focus on quality of life improvements and constitutional restoration.
Methods: A prospective case series was conducted over 12 months involving 37 breast cancer patients (Stage II-III) receiving conventional treatment alongside individualised homoeopathic medicines. Quality of life assessments were conducted using validated instruments at baseline, 3, 6, 9, and 12 months.
Results: Patients demonstrated significant improvements in quality-of-life parameters, including reduced chemotherapy-related side effects, enhanced post-surgical recovery, diminished radiation therapy complications, improved sleep quality, reduced anxiety, and better functional scores. Constitutional medicines typically required 8-9 months to achieve optimal therapeutic response due to the depleted vital state of patients following intensive conventional treatments.
Conclusions: Adjunctive homeopathic treatment appears to offer meaningful benefits in breast cancer care, particularly in managing treatment-related side effects and supporting constitutional recovery. The psychosomatic approach addressing separation conflicts showed clinical relevance consistent with German New Medicine principles.




